Cspc Pharmaceuti (CSPCY) Stock Price, News & Analysis
Company Description
Cspc Pharmaceuti (OTC Link: CSPCY) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $14.8B.
CSPCY has declined 10.1% over the past year. Shares last traded at $4.43.
This page collects what Stock Titan holds for CSPCY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cspc Pharmaceuti (CSPCY) stock last closed at $4.43. Over the past 12 months, the stock has lost 10.1%. At a market capitalization of $14.8B, CSPCY is classified as a large-cap stock with approximately 2.9B shares outstanding.
Latest News
Cspc Pharmaceuti has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all CSPCY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Cspc Pharmaceuti (CSPCY) currently stands at 3.9 thousand shares, up 1765.7% from the previous reporting period, representing 0.0% of the float. Since July 2025, short interest has increased by 19210.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cspc Pharmaceuti (CSPCY) currently stands at 2.4 days, up 135% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 135% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.4 days.
CSPCY Company Profile & Sector Positioning
Cspc Pharmaceuti (CSPCY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CSPCY often look at related companies in the same sector, including Astellas Pharma (ALPMY), Otsuka Holdings (OTSKY), Otsuka Holdings (OTSKF), Bayer Aktien (BAYRY), and Bayer A G (BAYZF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CSPCY's relative position within its industry.